{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:38:44Z","timestamp":1793032724229,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000038","name":"Natural Sciences and Engineering Research Council of Canada","doi-asserted-by":"publisher","award":["RGPIN-2025-04563"],"award-info":[{"award-number":["RGPIN-2025-04563"]}],"id":[{"id":"10.13039\/501100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013873","name":"Government of Ontario","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013873","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013779","name":"Retina Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012171","name":"Ontario Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000196","name":"Fondation canadienne pour l'innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics: X"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ijpx.2026.100619","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T15:29:26Z","timestamp":1784302166000},"page":"100619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development and characterization of a topical ferrochelatase inhibitor nanoemulsion for choroidal neovascularization therapy"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3044-8706","authenticated-orcid":false,"given":"Debadatta","family":"Mohapatra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2672-4707","authenticated-orcid":false,"given":"Seung-Yong","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1402-7875","authenticated-orcid":false,"given":"Timothy W.","family":"Corson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpx.2026.100619_bb0005","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/gels9060494","article-title":"Optimization of potential nanoemulgels for boosting transdermal glimepiride delivery and upgrading its anti-diabetic activity","volume":"9","author":"Abdallah","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ijpx.2026.100619_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123704","article-title":"Engineering a novel water-in-oil biocompatible microemulsion system for the ocular delivery of dexamethasone sodium phosphate in the treatment of acute uveitis","volume":"650","author":"Abd-Elaty","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0015","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2024.05.031","article-title":"In situ gelling systems for ocular drug delivery","volume":"371","author":"Ahmed","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100619_bb0020","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/gels9030178","article-title":"Phospholipid-based topical nano-hydrogel of Mangiferin: enhanced topical delivery and improved dermatokinetics","volume":"9","author":"Alkholifi","year":"2023","journal-title":"Gels"},{"key":"10.1016\/j.ijpx.2026.100619_bb0025","article-title":"Enhanced ocular delivery of clotrimazole via loading into mucoadhesive microemulsion system: in vitro characterization and in vivo assessment","volume":"64","author":"Al-mahallawi","year":"2021","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0030","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijpharm.2018.01.041","article-title":"In vitro stabilization and in vivo improvement of ocular pharmacokinetics of the multi-therapeutic agent baicalin: Delineating the most suitable vesicular systems","volume":"539","author":"Ashraf","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0035","article-title":"Prednisolone loaded-cationic nanoemulsion formulation for uveitis management","volume":"92","author":"Attia","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0040","doi-asserted-by":"crossref","first-page":"12419","DOI":"10.1096\/fj.202000964R","article-title":"Ferrochelatase regulates retinal neovascularization","volume":"34","author":"Babu","year":"2020","journal-title":"FASEB J."},{"key":"10.1016\/j.ijpx.2026.100619_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124391","article-title":"Fabrication of acetazolamide loaded leciplex for intraocular delivery: Optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics","volume":"661","author":"Bagul","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0050","first-page":"7303","article-title":"Infrared spectral composition of rose oil from Turkey","volume":"21","author":"Bardak\u00e7i","year":"2009","journal-title":"Asian J. Chem."},{"key":"10.1016\/j.ijpx.2026.100619_bb0055","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s13346-012-0109-8","article-title":"Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies","volume":"2","author":"Barot","year":"2012","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0060","doi-asserted-by":"crossref","first-page":"786","DOI":"10.15252\/emmm.201606561","article-title":"Ferrochelatase is a therapeutic target for ocular neovascularization","volume":"9","author":"Basavarajappa","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ijpx.2026.100619_bb0065","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.3390\/pharmaceutics16081092","article-title":"Formulation of polymeric nanoparticles loading baricitinib as a topical approach in ocular application","volume":"16","author":"Beirampour","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2022.119559","article-title":"In situ gelling microemulsion for topical ocular delivery of moxifloxacin and betamethasone","volume":"360","author":"Cardoso","year":"2022","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpx.2026.100619_bb0075","doi-asserted-by":"crossref","first-page":"2306479","DOI":"10.1002\/smll.202306479","article-title":"Long-acting microparticle formulation of griseofulvin for ocular neovascularization therapy","volume":"20","author":"Chobisa","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.ijpx.2026.100619_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2021.116751","article-title":"A comprehensive review on nanoemulsion as an ophthalmic drug delivery system","volume":"339","author":"Choradiya","year":"2021","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.ijpx.2026.100619_bb0085","article-title":"Development of ocular delivery systems for macitentan and ex vivo study of intraocular permeation","volume":"100","author":"Da Silva Gon\u00e7alves","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0090","doi-asserted-by":"crossref","first-page":"11453","DOI":"10.1016\/S0021-9258(17)44247-5","article-title":"Bovine ferrochelatase. Kinetic analysis of inhibition by N-methylprotoporphyrin, manganese, and heme","volume":"258","author":"Dailey","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpx.2026.100619_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cofs.2017.06.003","article-title":"Nanoemulsions: stability and physical properties","volume":"16","author":"De Oca-\u00c1valos","year":"2017","journal-title":"Curr. Opin. Food Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123840","article-title":"Triamcinolone-loaded self nano-emulsifying drug delivery systems for ocular use: an alternative to invasive ocular surgeries and injections","volume":"653","author":"Dehghani","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0105","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4274\/tjps.galenos.2020.59319","article-title":"Nanoemulsions as ophthalmic drug delivery systems","volume":"18","author":"Dhahir","year":"2021","journal-title":"Turk. J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0110","article-title":"Formulation and optimization of microemulsion based sparfloxacin in-situ gel for ocular delivery: in vitro and ex vivo characterization","volume":"55","author":"Dhaval","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0115","article-title":"Enhanced anti-cataract effect of microemulsion containing Cineraria maritima: Formulation, optimization and in vivo evaluation","volume":"77","author":"Durgapal","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0120","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1167\/tvst.11.5.16","article-title":"Delivery of hydrophobic drugs to the posterior ocular region by gel-in-water nanoemulsion","volume":"11","author":"Fardous","year":"2022","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0125","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s12272-024-01503-3","article-title":"Challenges and opportunities of developing small-molecule therapies for age-related macular degeneration","volume":"47","author":"Fei","year":"2024","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0130","article-title":"Development and characterization of nanoemulsions for ophthalmic applications: role of cationic surfactants","volume":"14","author":"Fernandes","year":"2021","journal-title":"Materials (Basel, Switzerland)"},{"key":"10.1016\/j.ijpx.2026.100619_bb0135","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","article-title":"Age-related macular degeneration: a review","volume":"331","author":"Fleckenstein","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.ijpx.2026.100619_bb0140","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ijpharm.2013.06.009","article-title":"Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro\/in vivo evaluation","volume":"453","author":"Fouad","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0145","first-page":"37","article-title":"Optimization of brinzolamide loaded microemulsion using formulation by design approach: characterization and in-vitro evaluation","volume":"15","author":"Gohil","year":"2020","journal-title":"Curr. Drug Ther."},{"key":"10.1016\/j.ijpx.2026.100619_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132643","article-title":"Optimization of an image-guided laser-induced choroidal neovascularization model in mice","volume":"10","author":"Gong","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpx.2026.100619_bb0155","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.bbamcr.2012.04.009","article-title":"One ring to rule them all: trafficking of heme and heme synthesis intermediates in the metazoans","volume":"1823","author":"Hamza","year":"2012","journal-title":"Biochim. Biophys. Acta Mol. Cell Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0160","article-title":"Cationic rifampicin nanoemulsion for the treatment of ocular tuberculosis","volume":"597","author":"Henostroza","year":"2020","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijpx.2026.100619_bb0165","series-title":"Wet Age-Related Macular Degeneration (AMD), StatPearls [Internet]","author":"Hobbs","year":"2024"},{"key":"10.1016\/j.ijpx.2026.100619_bb0170","first-page":"S172","article-title":"Review of neovascular age-related macular degeneration treatment options","volume":"25","author":"Holekamp","year":"2019","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ijpx.2026.100619_bb0175","doi-asserted-by":"crossref","first-page":"704","DOI":"10.3390\/pharmaceutics12080704","article-title":"Enhanced corneal penetration of a poorly permeable drug using bioadhesive multiple microemulsion technology","volume":"12","author":"Ibrahim","year":"2020","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119402","article-title":"Nanoemulsion as a feasible and biocompatible carrier for ocular delivery of travoprost: improved pharmacokinetic\/pharmacodynamic properties","volume":"583","author":"Ismail","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0185","doi-asserted-by":"crossref","first-page":"18996","DOI":"10.1038\/s41598-021-98568-7","article-title":"Patient preferences in retinal drug delivery","volume":"11","author":"Jacobs","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijpx.2026.100619_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.mex.2022.101809","article-title":"An improved method for murine laser-induced choroidal neovascularization lesion quantification from optical coherence tomography images","volume":"9","author":"Jensen","year":"2022","journal-title":"MethodsX"},{"key":"10.1016\/j.ijpx.2026.100619_bb0195","doi-asserted-by":"crossref","first-page":"886","DOI":"10.3109\/10717544.2014.920432","article-title":"Delivery of gatifloxacin using microemulsion as vehicle: formulation, evaluation, transcorneal permeation and aqueous humor drug determination","volume":"23","author":"Kalam","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100619_bb0200","first-page":"1","article-title":"Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation","author":"Kassaee","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0205","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/08839115231167587","article-title":"Fabrication of poloxamer based besifloxacin thermosensitive in situ gelling nanoemulsions for ophthalmic delivery","volume":"38","author":"Kassaee","year":"2023","journal-title":"J. Bioact. Compat. Polym."},{"key":"10.1016\/j.ijpx.2026.100619_bb0210","article-title":"Formulation and optimization of cationic nanoemulsions for enhanced ocular delivery of dorzolamide hydrochloride using Box-Behnken design: in vitro and in vivo assessments","volume":"68","author":"Kassem","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0215","first-page":"25","article-title":"Formulation and evaluation of nimodipine nano crystal for ophthalmic drug delivery system","volume":"13","author":"Kiran","year":"2024","journal-title":"Int. J. Pharm. Sci. Invent."},{"key":"10.1016\/j.ijpx.2026.100619_bb0220","first-page":"30224","article-title":"Oil-in-water nanoemulsions for glaucoma treatment: an insight into the latest trends","volume":"15","author":"Kishore","year":"2024","journal-title":"Bioimpacts"},{"key":"10.1016\/j.ijpx.2026.100619_bb0225","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1002\/jps.23251","article-title":"Nanostructured lipid carriers as novel ophthalmic delivery system for mangiferin: improving in vivo ocular bioavailability","volume":"101","author":"Liu","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0230","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bcp.2015.09.002","article-title":"A metabolomic perspective of griseofulvin-induced liver injury in mice","volume":"98","author":"Liu","year":"2015","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0235","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/10717544.2021.2021323","article-title":"Development of a naringenin microemulsion as a prospective ophthalmic delivery system for the treatment of corneal neovascularization: in vitro and in vivo evaluation","volume":"29","author":"Ma","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100619_bb0240","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/jnt5040010","article-title":"Drug delivery systems for infectious eye diseases: Advancements and prospects","volume":"5","author":"Mahaling","year":"2024","journal-title":"J. Nanotheranostics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0245","first-page":"847","article-title":"Formulation development and evaluation of the therapeutic efficacy of brinzolamide containing nanoemulsions","volume":"16","author":"Mahboobian","year":"2017","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0250","article-title":"Development of thermosensitive in situ gel nanoemulsions for ocular delivery of acyclovir","volume":"55","author":"Mahboobian","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0255","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3390\/pharmaceutics13040444","article-title":"Development of triamcinolone acetonide-loaded microemulsion as a prospective ophthalmic delivery system for treatment of uveitis: in vitro and in vivo evaluation","volume":"13","author":"Mahran","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121105","article-title":"Recent advances in ophthalmic preparations: Ocular barriers, dosage forms and routes of administration","volume":"608","author":"Maulvi","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0265","first-page":"93","article-title":"Design of novel nanoemulsion formulations for topical ocular delivery of itraconazole: development, characterization and in vitro bioassay","volume":"12","author":"Mehrandish","year":"2021","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.ijpx.2026.100619_bb0270","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2217\/nnm-2021-0190","article-title":"Carbon dots from an immunomodulatory plant for cancer cell imaging, free radical scavenging and metal sensing applications","volume":"16","author":"Mohapatra","year":"2021","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100619_bb0275","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2217\/nnm-2023-0069","article-title":"Quality-by-design-based development of ultradeformable nanovesicular transgelosome of standardized Piper longum extract for melanoma","volume":"18","author":"Mohapatra","year":"2023","journal-title":"Nanomedicine"},{"key":"10.1016\/j.ijpx.2026.100619_bb0280","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/20415990.2024.2363136","article-title":"Quality-by-design-based microemulsion of disulfiram for repurposing in melanoma and breast cancer therapy","volume":"15","author":"Mohapatra","year":"2024","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpx.2026.100619_bb0285","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/pharmaceutics17121504","article-title":"Emulsion and emulgel-based ophthalmic drug delivery systems","volume":"17","author":"Mohapatra","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0290","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s10456-024-09966-0","article-title":"Ref-1 is overexpressed in neovascular eye disease and targetable with a novel inhibitor","volume":"28","author":"Muniyandi","year":"2025","journal-title":"Angiogenesis"},{"key":"10.1016\/j.ijpx.2026.100619_bb0295","first-page":"1","article-title":"Design, preparation and in-vitro evaluation of novel ocular antifungal nanoemulsion using posaconazole as a model drug","volume":"11","author":"Nasser","year":"2021","journal-title":"Int. J. Drug Deliv. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0300","doi-asserted-by":"crossref","first-page":"7928","DOI":"10.1021\/acsomega.9b04244","article-title":"Triamcinolone acetonide-loaded PEGylated microemulsion for the posterior segment of eye","volume":"5","author":"Nayak","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijpx.2026.100619_bb0305","article-title":"Limonene-enriched ultra-structural cubosomes to augment ocular delivery of a poorly water soluble anti-fungal drug: Fabrication, characterization, statistical optimization, in vivo corneal uptake and histopathological evaluation in rabbits","volume":"98","author":"Nemr","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bib441","series-title":"OECD guidelines for the testing of chemicals, section 4: test no. 405: acute eye irritation\/corrosion","year":"2023"},{"key":"10.1016\/j.ijpx.2026.100619_bb0310","first-page":"560613","article-title":"Preparation and characterization of self emulsifying solid dispersions of mebendazole to improve solubility","volume":"4","author":"Pervaiz","year":"2026","journal-title":"Int. J. Pharm. Integr. Health Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0315","doi-asserted-by":"crossref","first-page":"6525","DOI":"10.1167\/iovs.14-15067","article-title":"Reliability of the mouse model of choroidal neovascularization induced by laser photocoagulation","volume":"55","author":"Poor","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0320","article-title":"Development of ophthalmic nanoemulsions of \u03b2-caryophyllene for the treatment of Acanthamoeba keratitis","volume":"659","author":"Porto","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0325","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/02652048.2018.1425750","article-title":"Microemulsion-based delivery of triamcinolone acetonide to posterior segment of eye using chitosan and butter oil as permeation enhancer: an in vitro and in vivo investigation","volume":"35","author":"Raval","year":"2018","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ijpx.2026.100619_bb0330","article-title":"Ocular mucoadhesive and biodegradable spanlastics loaded cationic spongy insert for enhancing and sustaining the anti-inflammatory effect of prednisolone Na phosphate; Preparation, I-optimal optimization, and In-vivo evaluation","volume":"8","author":"Said","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0335","first-page":"5","article-title":"Ocular delivery of ketorolac tromethamine using microemulsion as a vehicle: Design, evaluation, and transcorneal permeation","volume":"3","author":"Salimi","year":"2020","journal-title":"J. Res. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0340","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.jconrel.2020.10.054","article-title":"Nanodiagnostics and nanotherapeutics for age-related macular degeneration","volume":"329","author":"Sarkar","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100619_bb0345","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/03639045.2017.1408643","article-title":"Oral bioavailability enhancement of raloxifene by developing microemulsion using D-optimal mixture design: optimization and in-vivo pharmacokinetic study","volume":"44","author":"Shah","year":"2018","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0350","first-page":"130","article-title":"Formulation and evaluation of ocusert embeded with ciprofloxacin loaded nanoparticles","volume":"7","author":"Shaikh","year":"2024","journal-title":"Int. J. Adv. Life Sci. Res."},{"key":"10.1016\/j.ijpx.2026.100619_bb0355","doi-asserted-by":"crossref","first-page":"101391","DOI":"10.1016\/j.isci.2020.101391","article-title":"Heme synthesis inhibition blocks angiogenesis via mitochondrial dysfunction","volume":"23","author":"Shetty","year":"2020","journal-title":"iScience"},{"key":"10.1016\/j.ijpx.2026.100619_bb0360","doi-asserted-by":"crossref","first-page":"1157084","DOI":"10.3389\/fphar.2023.1157084","article-title":"Preparation of a sunitinib loaded microemulsion for ocular delivery and evaluation for the treatment of corneal neovascularization in vitro and in vivo","volume":"14","author":"Shi","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0365","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jconrel.2020.10.025","article-title":"Therapeutic nanoemulsions in ophthalmic drug administration: Concept in formulations and characterization techniques for ocular drug delivery","volume":"328","author":"Singh","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpx.2026.100619_bb0370","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.chembiol.2022.01.001","article-title":"Small-molecule inhibitors of ferrochelatase are antiangiogenic agents","volume":"29","author":"Sishtla","year":"2022","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0375","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13040467","article-title":"Studies on surfactants, cosurfactants, and oils for prospective use in formulation of ketorolac tromethamine ophthalmic nanoemulsions","volume":"13","author":"Smail","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/jop.2015.0049","article-title":"A simple optical coherence tomography quantification method for choroidal neovascularization","volume":"31","author":"Sulaiman","year":"2015","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"10.1016\/j.ijpx.2026.100619_bb0385","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1016\/j.xphs.2024.07.023","article-title":"Small molecule topical ophthalmic formulation development\u2013data driven trends & perspectives from commercially available products in the US","volume":"113","author":"Ubhe","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpx.2026.100619_bb0390","article-title":"Formulation and evaluation of ocular self-nanoemulsifying drug delivery system of brimonidine tartrate","volume":"81","author":"Vikash","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ijpx.2026.100619_bb0395","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","article-title":"Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis","volume":"2","author":"Wong","year":"2014","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ijpx.2026.100619_bb0400","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.3390\/pharmaceutics14102052","article-title":"Development of a luliconazole nanoemulsion as a prospective ophthalmic delivery system for the treatment of fungal keratitis: in vitro and in vivo evaluation","volume":"14","author":"Yang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0405","article-title":"Formulation, optimization and evaluation of ocular gel containing nebivolol HCl-loaded ultradeformable spanlastics nanovesicles: in vitro and in vivo studies","volume":"7","author":"Yasser","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpx.2026.100619_bb0410","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/ph14030210","article-title":"Design of topical ocular ciprofloxacin nanoemulsion for the management of bacterial keratitis","volume":"14","author":"Youssef","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpx.2026.100619_bb0415","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3390\/pharmaceutics14061246","article-title":"Design of topical moxifloxacin mucoadhesive nanoemulsion for the management of ocular bacterial infections","volume":"14","author":"Youssef","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijpx.2026.100619_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fmats.2024.1363138","article-title":"Formulation and evaluation of ophthalmic microemulsion for enhanced topical administration of brinzolamide","volume":"11","author":"Zafar","year":"2024","journal-title":"Front. Mater."},{"key":"10.1016\/j.ijpx.2026.100619_bb0425","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1366\/000370210790571918","article-title":"Fourier transform infrared analysis of the thermal modification of human cornea tissue during conductive keratoplasty","volume":"64","author":"Zhang","year":"2010","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.ijpx.2026.100619_bb0430","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1080\/10717544.2022.2096714","article-title":"Preparation and in vitro and in vivo evaluation of an isoliquiritigenin-loaded ophthalmic nanoemulsion for the treatment of corneal neovascularization","volume":"29","author":"Zhang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ijpx.2026.100619_bb0435","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.3390\/ph16101342","article-title":"Development of osthole-loaded microemulsions as a prospective ocular delivery system for the treatment of corneal neovascularization: in vitro and in vivo assessments","volume":"16","author":"Zhang","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ijpx.2026.100619_bb0440","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3390\/pharmaceutics16010125","article-title":"Formulating resveratrol and melatonin self-nanoemulsifying drug delivery systems (SNEDDS) for ocular administration using design of experiments","volume":"16","author":"Zingale","year":"2024","journal-title":"Pharmaceutics"}],"container-title":["International Journal of Pharmaceutics: X"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2590156726001398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T16:01:59Z","timestamp":1793030519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2590156726001398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":89,"alternative-id":["S2590156726001398"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100619","relation":{},"ISSN":["2590-1567"],"issn-type":[{"value":"2590-1567","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and characterization of a topical ferrochelatase inhibitor nanoemulsion for choroidal neovascularization therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics: X","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpx.2026.100619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100619"}}